These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37835479)

  • 1. Alteration of the Exhaled Volatile Organic Compound Pattern in Colorectal Cancer Patients after Intentional Curative Surgery-A Prospective Pilot Study.
    Hanevelt J; Schoenaker IJH; Brohet RM; Schrauwen RWM; Baas FJN; Tanis PJ; van Westreenen HL; de Vos Tot Nederveen Cappel WH
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonoseā„¢): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
    Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
    Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of differentiated thyroid carcinoma in exhaled breath with an electronic nose.
    Scheepers MHMC; Al-Difaie ZJJ; Wintjens AGWE; Engelen SME; Havekes B; Lubbers T; Coolsen MME; van der Palen J; van Ginhoven TM; Vriens M; Bouvy ND
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35688135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting multiple sclerosis via breath analysis using an eNose, a pilot study.
    Ettema AR; Lenders MWPM; Vliegen J; Slettenaar A; Tjepkema-Cloostermans MC; de Vos CC
    J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33271513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
    Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
    van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
    Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of volatile organic compounds analysis and electronic noses for detecting colorectal cancer: a systematic review and meta-analysis.
    Wang Q; Fang Y; Tan S; Li Z; Zheng R; Ren Y; Jiang Y; Huang X
    Front Oncol; 2024; 14():1397259. PubMed ID: 38817891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the electronic nose for pre-operative SARS-CoV-2 screening.
    Wintjens AGWE; Hintzen KFH; Engelen SME; Lubbers T; Savelkoul PHM; Wesseling G; van der Palen JAM; Bouvy ND
    Surg Endosc; 2021 Dec; 35(12):6671-6678. PubMed ID: 33269428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Diagnosis through Breath Test Using a Portable Breath Analyzer-Preliminary Data.
    Picciariello A; Dezi A; Vincenti L; Spampinato MG; Zang W; Riahi P; Scott J; Sharma R; Fan X; Altomare DF
    Sensors (Basel); 2024 Apr; 24(7):. PubMed ID: 38610554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
    Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
    Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.
    Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds.
    Bosch S; Bot R; Wicaksono A; Savelkoul E; van der Hulst R; Kuijvenhoven J; Stokkers P; Daulton E; Covington JA; de Meij TGJ; de Boer NKH
    Colorectal Dis; 2020 Sep; 22(9):1119-1129. PubMed ID: 32040880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled volatile organic compounds identify patients with colorectal cancer.
    Altomare DF; Di Lena M; Porcelli F; Trizio L; Travaglio E; Tutino M; Dragonieri S; Memeo V; de Gennaro G
    Br J Surg; 2013 Jan; 100(1):144-50. PubMed ID: 23212621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled volatile organic compounds in the detection of colorectal cancer: a systematic review and meta-analysis.
    Alsaadi D; Clements N; Gabuniya N; Francis N; Chand M
    EXCLI J; 2024; 23():795-810. PubMed ID: 38983779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer.
    Chandrapalan S; Bosch S; Cubiella J; Guardiola J; Kimani P; Mulder C; Persaud K; de Meij TGJ; Altomare DF; Brenner H; de Boer NKH; Ricciardiello L; Arasaradnam RP
    Aliment Pharmacol Ther; 2021 Jul; 54(1):14-23. PubMed ID: 34004036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.